DEVELOPMENT AND VALIDATION OF METHODS OF QUANTITATIVE DETERMINATION OF THE NEW ANTIDIABETIC DRUG IN THE BLOOD PLASMA OF RATS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH MASS SPECTROMETRIC DETECTION

We developed a method of quantification of the new antidiabetic drug 3-(1h-benzimidazole-2-yl)-1,2,2-trimethyl-cyclopentane-carbonic acid (c7070) in the blood plasma of rats by high-performance liquid chromatography with mass-spectrometric detection. The analytical range of the method was 0.02-3876....

Full description

Bibliographic Details
Published in:RESEARCH RESULT Pharmacology and Clinical Pharmacology
Main Authors: Buzov,Andrey, Kulikov,Alexandr, Avtina,Tatyana, Pokrovskii,Mikhail, Osipova,Ol'ga
Format: Article in Journal/Newspaper
Language:English
Published: Belgorod National Research University 2016
Subjects:
antidiabetic agent
С7070
the blood plasma of rats
high-performance liquid chromatography
mass spectrometric detection
validation
Carbonic acid
Online Access:https://doi.org/10.18413/2313-8971-2016-2-1-52-57
https://rrpharmacology.ru/article/31041/
Description
Summary:We developed a method of quantification of the new antidiabetic drug 3-(1h-benzimidazole-2-yl)-1,2,2-trimethyl-cyclopentane-carbonic acid (c7070) in the blood plasma of rats by high-performance liquid chromatography with mass-spectrometric detection. The analytical range of the method was 0.02-3876.0 μg in 1 ml of blood plasma. The research was partially supported by the grant of the President of the Russian Federation № MD-4711.2015.7 and МК-6135.2016.4.

Similar Items